Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is one of the deadliest malignancies. Aging is described as the degeneration of physiological function, which is complexly correlated with cancer. It is significant to explore the influences of aging-related genes (ARGs) on PAAD. Based on The Cancer Genome Atlas (TCG...

Full description

Bibliographic Details
Main Authors: Shengbai Xue, Weiyu Ge, Kexuan Wang, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Yongchao Wang, Jiayu Yao, Shumin Li, Ming Yue, Jingyu Ma, Yanling Wang, Daiyuan Shentu, Jiujie Cui, Liwei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.942225/full
_version_ 1798041151505170432
author Shengbai Xue
Weiyu Ge
Kexuan Wang
Tiebo Mao
Xiaofei Zhang
Haiyan Xu
Yongchao Wang
Jiayu Yao
Shumin Li
Ming Yue
Jingyu Ma
Yanling Wang
Daiyuan Shentu
Jiujie Cui
Liwei Wang
author_facet Shengbai Xue
Weiyu Ge
Kexuan Wang
Tiebo Mao
Xiaofei Zhang
Haiyan Xu
Yongchao Wang
Jiayu Yao
Shumin Li
Ming Yue
Jingyu Ma
Yanling Wang
Daiyuan Shentu
Jiujie Cui
Liwei Wang
author_sort Shengbai Xue
collection DOAJ
description Pancreatic adenocarcinoma (PAAD) is one of the deadliest malignancies. Aging is described as the degeneration of physiological function, which is complexly correlated with cancer. It is significant to explore the influences of aging-related genes (ARGs) on PAAD. Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) datasets, we used univariate Cox regression analysis and acquired eight differentially expressed ARGs with prognostic values. Two molecular subtypes were identified based on these ARGs to depict PAAD patients’ overall survival (OS) and immune microenvironments preliminarily. Cluster 1 had a poor OS as well as a worse immune microenvironment. Through least absolute shrinkage and selection operator (LASSO) regression analysis, we constructed a seven-ARG risk signature based on the TCGA dataset and verified it in Gene Expression Omnibus (GEO) and International Cancer Genome Consortium (ICGC) to predict the prognoses, immune microenvironments, signal pathways, tumor mutations, and drug sensitivity of PAAD patients. The high-risk group possessed an unfavorable OS compared with that of the low-risk group. We also verified the independence and clinical availability of the risk signature by Cox regression analyses and the establishment of a nomogram, respectively. The higher risk score was associated with several clinical factors such as higher grade and advanced tumor stage as well as lower immunoscore and cluster 1. The negative associations of risk scores with immune, stroma, and estimate scores proved the terrible immune microenvironment in the high-risk group. Relationships between risk score and immune checkpoint gene expression as well as signal pathways provided several therapeutic targets. PAAD patients in the low-risk group possessed lower tumor mutations as well as a higher susceptibility to axitinib and vorinostat. The high-risk group bore a higher TMB and cisplatin and dasatinib may be better options. We used immunohistochemistry and qPCR to confirm the expression of key ARGs with their influences on OS. In conclusion, we identified two ARG-mediated molecular subtypes and a novel seven-ARG risk signature to predict prognoses, immune microenvironments, signal pathways, tumor mutations, and drug sensitivity of PAAD patients.
first_indexed 2024-04-11T22:17:30Z
format Article
id doaj.art-96d3ea86bb7041bf88f8373f16bb37c0
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-11T22:17:30Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-96d3ea86bb7041bf88f8373f16bb37c02022-12-22T04:00:19ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-08-011010.3389/fcell.2022.942225942225Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinomaShengbai Xue0Weiyu Ge1Kexuan Wang2Tiebo Mao3Xiaofei Zhang4Haiyan Xu5Yongchao Wang6Jiayu Yao7Shumin Li8Ming Yue9Jingyu Ma10Yanling Wang11Daiyuan Shentu12Jiujie Cui13Liwei Wang14Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Nursing, School of Nursing, Xuzhou Medical University, Xuzhou, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaDepartment of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, ChinaPancreatic adenocarcinoma (PAAD) is one of the deadliest malignancies. Aging is described as the degeneration of physiological function, which is complexly correlated with cancer. It is significant to explore the influences of aging-related genes (ARGs) on PAAD. Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) datasets, we used univariate Cox regression analysis and acquired eight differentially expressed ARGs with prognostic values. Two molecular subtypes were identified based on these ARGs to depict PAAD patients’ overall survival (OS) and immune microenvironments preliminarily. Cluster 1 had a poor OS as well as a worse immune microenvironment. Through least absolute shrinkage and selection operator (LASSO) regression analysis, we constructed a seven-ARG risk signature based on the TCGA dataset and verified it in Gene Expression Omnibus (GEO) and International Cancer Genome Consortium (ICGC) to predict the prognoses, immune microenvironments, signal pathways, tumor mutations, and drug sensitivity of PAAD patients. The high-risk group possessed an unfavorable OS compared with that of the low-risk group. We also verified the independence and clinical availability of the risk signature by Cox regression analyses and the establishment of a nomogram, respectively. The higher risk score was associated with several clinical factors such as higher grade and advanced tumor stage as well as lower immunoscore and cluster 1. The negative associations of risk scores with immune, stroma, and estimate scores proved the terrible immune microenvironment in the high-risk group. Relationships between risk score and immune checkpoint gene expression as well as signal pathways provided several therapeutic targets. PAAD patients in the low-risk group possessed lower tumor mutations as well as a higher susceptibility to axitinib and vorinostat. The high-risk group bore a higher TMB and cisplatin and dasatinib may be better options. We used immunohistochemistry and qPCR to confirm the expression of key ARGs with their influences on OS. In conclusion, we identified two ARG-mediated molecular subtypes and a novel seven-ARG risk signature to predict prognoses, immune microenvironments, signal pathways, tumor mutations, and drug sensitivity of PAAD patients.https://www.frontiersin.org/articles/10.3389/fcell.2022.942225/fullpancreatic adenocarcinomaagingmolecular subtypeprognostic signatureimmune microenviroment
spellingShingle Shengbai Xue
Weiyu Ge
Kexuan Wang
Tiebo Mao
Xiaofei Zhang
Haiyan Xu
Yongchao Wang
Jiayu Yao
Shumin Li
Ming Yue
Jingyu Ma
Yanling Wang
Daiyuan Shentu
Jiujie Cui
Liwei Wang
Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
Frontiers in Cell and Developmental Biology
pancreatic adenocarcinoma
aging
molecular subtype
prognostic signature
immune microenviroment
title Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
title_full Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
title_fullStr Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
title_full_unstemmed Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
title_short Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
title_sort association of aging related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
topic pancreatic adenocarcinoma
aging
molecular subtype
prognostic signature
immune microenviroment
url https://www.frontiersin.org/articles/10.3389/fcell.2022.942225/full
work_keys_str_mv AT shengbaixue associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT weiyuge associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT kexuanwang associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT tiebomao associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT xiaofeizhang associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT haiyanxu associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT yongchaowang associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT jiayuyao associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT shuminli associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT mingyue associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT jingyuma associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT yanlingwang associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT daiyuanshentu associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT jiujiecui associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma
AT liweiwang associationofagingrelatedgeneswithprognosisandimmuneinfiltrationinpancreaticadenocarcinoma